SCHOLARLY PUBLICATION

A Variable-dosing Regimen with Intravitreal Ranibizumab for Neovascular Age-related Macular Degeneration: Year 2 of the PrONTO Study

Geeta A. Lalwani, Philip J. Rosenfeld, Anne E. Fung, Sander R. Dubovy, S. Michels, William J. Feuer, Janet L. Davis, Harry W. Flynn, Maria Esquiabro

📖 American Journal of Ophthalmology → 📅 2009-04-20 🔗 DOI: 10.1016/j.ajo.2009.01.024

View Journal Profile → View Official Paper ↗

📄 Abstract

The abstract has not yet been added. Use the official source link for the complete publication record.

ℹ️ Publication Details

Journal: American Journal of Ophthalmology
Published: 2009-04-20
DOI: 10.1016/j.ajo.2009.01.024
OpenAlex: W2075984382
Access: Via publisher

📋 Cite This Paper

Geeta A. Lalwani, Philip J. Rosenfeld, Anne E. Fung, Sander R. Dubovy, S. Michels, William J. Feuer, Janet L. Davis, Harry W. Flynn, Maria Esquiabro (2009). A Variable-dosing Regimen with Intravitreal Ranibizumab for Neovascular Age-related Macular Degeneration: Year 2 of the PrONTO Study. American Journal of Ophthalmology. https://doi.org/10.1016/j.ajo.2009.01.024

🔬 Related Research Papers

American Journal of Ophthalmology

Prevalence of Diagnosed Dry Eye Disease in the United States Among Adults Aged 18 Years and Older

Kimberly F Farrand, Moshe Fridman et al. 2017-07-10 · Read paper → American Journal of Ophthalmology

Epidemiology and Disease Burden of Pathologic Myopia and Myopic Choroidal Neovascularization: An Evidence-Based Systematic Review

Tien Yin Wong, Alberto Ferreira et al. 2013-10-05 · Read paper → American Journal of Ophthalmology

Randomized, Double-Masked, Sham-Controlled Trial of Ranibizumab for Neovascular Age-related Macular Degeneration: PIER Study Year 1

Carl D. Regillo, David M. Brown et al. 2008-01-28 · Read paper → American Journal of Ophthalmology

International Photographic Classification and Grading System for Myopic Maculopathy

Kyoko Ohno‐Matsui, Kyoko Ohno-Matsui et al. 2015-01-26 · Read paper → American Journal of Ophthalmology

An Optical Coherence Tomography-Guided, Variable Dosing Regimen with Intravitreal Ranibizumab (Lucentis) for Neovascular Age-related Macular Degeneration

Anne E. Fung, Geeta A. Lalwani et al. 2007-03-28 · Read paper → American Journal of Ophthalmology

📄 Abstract

🔬 Related Research Papers

Prevalence of Diagnosed Dry Eye Disease in the United States Among Adults Aged 18 Years and Older

Epidemiology and Disease Burden of Pathologic Myopia and Myopic Choroidal Neovascularization: An Evidence-Based Systematic Review

Enhanced Depth Imaging Optical Coherence Tomography of the Choroid in Highly Myopic Eyes

Postoperative Complications in the Tube Versus Trabeculectomy (TVT) Study During Five Years of Follow-up

Impact of Dry Eye Syndrome on Vision-Related Quality of Life

Randomized, Double-Masked, Sham-Controlled Trial of Ranibizumab for Neovascular Age-related Macular Degeneration: PIER Study Year 1

International Photographic Classification and Grading System for Myopic Maculopathy

An Optical Coherence Tomography-Guided, Variable Dosing Regimen with Intravitreal Ranibizumab (Lucentis) for Neovascular Age-related Macular Degeneration

Treatment Outcomes in the Tube Versus Trabeculectomy (TVT) Study After Five Years of Follow-up

A Pilot Study of Enhanced Depth Imaging Optical Coherence Tomography of the Choroid in Normal Eyes

Enhanced Depth Imaging Spectral-Domain Optical Coherence Tomography

Standardization of Uveitis Nomenclature for Reporting Clinical Data. Results of the First International Workshop